Ballantine Kirsten R, Watson Heidi, Macfarlane Scott, Winstanley Mark, Corbett Robin P, Spearing Ruth, Stevanovic Vladimir, Yi Ma, Sullivan Michael J
1 National Child Cancer Network NZ , Auckland, New Zealand .
2 Children's Haematology Oncology Centre, Christchurch Hospital , Christchurch, New Zealand .
J Adolesc Young Adult Oncol. 2017 Jun;6(2):277-285. doi: 10.1089/jayao.2016.0074. Epub 2017 Feb 16.
This study was undertaken to determine cancer survival and describe the unique spectrum of cancers diagnosed among New Zealand's adolescents and young adult (AYA) population.
Registrations for 1606 15-24 year olds diagnosed with a new primary malignant tumor between 2000 and 2009 were obtained from the New Zealand Cancer Registry and classified according to AYA diagnostic group and subgroup, age, sex, and prioritized ethnicity. Age-standardized incidence rates (IRs) per million person years and 5-year relative survival ratios were calculated.
Cancer incidence was 228.6 per million for adolescents aged 15-19 years and 325.7 per million for young adults aged 20-24 years. Overall IRs were consistent across all ethnic groups but there were unique ethnic differences by tumor group including a higher incidence of bone tumors, carcinoma of the gastrointestinal tract, and gonadal germ cell tumors among Maori, a higher incidence of leukemia among Pacific peoples, and a higher incidence of melanoma among non-Maori/non-Pacific peoples. Five-year relative survival for adolescents (75.1%) and AYA overall (80.6%) appeared poorer than had been achieved in other high-income countries. Maori (69.5%) and Pacific (71.3%) AYA had lower 5-year survival compared to non-Maori/non-Pacific peoples (84.2%).
The survival disparities observed require further investigation to identify and address the causes of these inferior outcomes. The newly established AYA Cancer Network Aotearoa has been tasked with improving cancer survival and care and ensuring equality of access for New Zealand AYAs with cancer.
开展本研究以确定癌症生存率,并描述在新西兰青少年和青年(AYA)人群中诊断出的癌症的独特谱系。
从新西兰癌症登记处获取了2000年至2009年间被诊断患有新发原发性恶性肿瘤的1606名15至24岁患者的登记信息,并根据AYA诊断组和亚组、年龄、性别以及优先种族进行分类。计算了每百万人口年的年龄标准化发病率(IRs)和5年相对生存率。
15至19岁青少年的癌症发病率为每百万228.6例,20至24岁青年的癌症发病率为每百万325.7例。所有种族的总体发病率一致,但不同肿瘤组存在独特的种族差异,包括毛利人中骨肿瘤、胃肠道癌和性腺生殖细胞肿瘤的发病率较高,太平洋岛民中白血病的发病率较高,非毛利/非太平洋岛民中黑色素瘤的发病率较高。青少年(75.1%)和AYA总体(80.6%)的5年相对生存率似乎低于其他高收入国家。与非毛利/非太平洋岛民(84.2%)相比,毛利(69.5%)和太平洋岛民(71.3%)的AYA的5年生存率较低。
观察到的生存差异需要进一步调查,以确定并解决这些较差结果的原因。新成立的新西兰青少年和青年癌症网络的任务是提高癌症生存率和护理水平,并确保新西兰患癌的青少年和青年能够平等获得医疗服务。